CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review Nitrosative stress drives heart failure with preserved ejection fraction Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead? Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure HFpEF: From Mechanisms to Therapies Heart Failure With Preserved Ejection Fraction in the Young Functional Impairment and Medication Burden in Adults With Heart Failure

Clinical Trial2016 Apr;35(4):528-36.

JOURNAL:J Heart Lung Transplant. Article Link

Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol

Heatley G, Sood P, MOMENTUM 3 Investigators. Keywords: HeartMate 3; LVAD; MOMENTUM 3; MagLev; advanced heart failure

FULL TEXT PDF